Business Insider

Interscope announces new FDA Clearance of the EndoRotor®, for use in Airway procedures including in Interventional Pulmonology

WHITINSVILLE, Mass., Dec. 19, 2019 /PRNewswire/ -- Interscope, Inc. announced today the receipt of marketing clearance from the FDA for the EndoRotor® System to commercialize Pulmonary indications.
WBJournal

Interscope gets FDA clearance for EndoRotor

Worcester medical device maker Interscope Inc. announced late Tuesday that it received clearance from the U.S. Food and Drug Administration for its EndoRotor System to commercialize in ...
Becker's ASC

FDA expands approval for Interscope’s EndoRotor — 3 insights

The FDA expanded its approval of Interscope’s EndoRotor System to allow the device to be used in the pulmonary space. 1. The EndoRotor system was the first flexible microdebrider for the digestive ...
Medscape

FDA Clears Device to Remove Dead Pancreatic Tissue

The US Food and Drug Administration (FDA) has approved the EndoRotor System (Interscope, Inc) for removal of necrotic tissue in patients with walled-off pancreatic necrosis (WOPN). "This device has ...
WBJournal

After European roll out, Interscope looks towards FDA approval

When the Affordable Care Act started to take shape, Jeff Ryan and Ramon Franco saw an opportunity in the medical device field. Inspired by the part of the law focused on preventative care, the two men ...
Becker's ASC

FDA awards 1st GI Shaver EndoRotor market clearance: 4 key notes

Here’s what you need to know about the first gastroenterology-facing flexible shaver technology. 1. Physicians can use the EndoRotor System in colorectal surgery. 2. Clinical data shows incomplete ...
News Medical

FDA authorizes first device to treat patients with walled-off pancreatic necrosis

Today, the U.S. Food and Drug Administration authorized marketing of the EndoRotor System to resect (cut out) and remove necrotic (dead) tissue for patients with walled-off pancreatic necrosis (WOPN), ...
Pharmabiz

Interscope receives US FDA de novo marketing authorization of EndoRotor System for direct endoscopic necrosectomy

Interscope, Inc. announced the receipt of FDA de novo clearance to market its EndoRotor System in the United States for direct endoscopic necrosectomy (DEN), a minimally invasive treatment for ...
Stockhouse

Micro-Tech Endoscopy and Interscope Announce Partnership & Extended FDA Clearance for EndoRotor® System

- Interscope, Inc. and Micro-Tech Endoscopy signed a partnership agreement focused on the distribution of Interscope's unique EndoRotor System for gastroenterology. - EndoRotor is now the first and ...
Business Insider

FDA authorizes marketing of new device designed to remove dead pancreatic tissue

SILVER SPRING, Md., Dec. 23, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration authorized marketing of the EndoRotor System to resect (cut out) and remove necrotic (dead) tissue for ...
BioWorld

Interscope receives FDA de novo marketing authorization for direct endoscopic necrosectomy, inks Micro-Tech Endoscopy agreement

The U.S. FDA granted de novo marketing authorization to Interscope Inc.’s Endorotor system for direct endoscopic necrosectomy (DEN) of walled-off pancreatic necrosis, giving the specialty device a ...
Stockhouse

Interscope Announces FDA De Novo Marketing Authorization of the EndoRotor® System for Direct Endoscopic Necrosectomy (DEN)

NORTHBRIDGE, Mass. , Dec. 24, 2020 /PRNewswire/ -- Interscope, Inc. announced today the receipt of FDA de novo clearance to market its EndoRotor® System in the United States for direct ...